The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial)

This study has been terminated.

( Inability to recruit )

Study NCT00343499 Information provided by Intermountain Health Care, Inc.

First Received: June 21, 2006 Last Updated: August 20, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	July 2007
Estimated Primary Completion Date:	No date given